|
||
|
|
||
InfertilityIn Australia, infertility can affect 1:6 couples. Healthscope Molecular offer a range of services to identify genetic changes which may lead to infertility. Recent medical publications and presentations at international IVF conferences have stated a significant percentage of embryos used in IVF may contain chromosomal abnormalities that can lead to miscarriage or pregnancy failure. Most experts suggest genetically testing the embryos prior to implantation will lead to improved IVF pregnancy rates. Healthscope Molecular offers IVF companies a technology to screen single cells that have been safely removed from embryos to identify DNA abnormalities. This increases the likelihood of pregnancy and birth by enabling IVF clinics to identify those embryos most likely to implant. At the same time, the technology provides for DNA fingerprinting to occur, thereby matching the implanted embryo with that of its true parents. |
||